Performance of point-of-care urine test in diagnosing tuberculosis suspects with and without HIV infection in selected peripheral health settings of Addis Ababa, Ethiopia.

PubWeight™: 0.75^‹?›

🔗 View Article (PMID 28137314)

Published in BMC Res Notes on January 31, 2017

Authors

Selam Niguse Sahle¹, Dereje Teshome Asress², Kassu Desta Tullu³, Atsebeha Gebrezgeaxier Weldemariam⁴, Habteyes Hailu Tola⁴, Yodit Alemayehu Awas⁴, Gebremdihin Gebremichael Hagos⁴, Muluwork Getahun Worku⁴, Desta Kassa Misgina⁴

Author Affiliations

1: Medical Microbiology and Immunology Unit, Institute of Biomedical Sciences, Mekelle University, PO. Box: 1871, Mekelle, Ethiopia. selamniguse@gmail.com.
2: College of Health Sciences, Addis Ababa Science and Technology University, Addis Ababa, Ethiopia.
3: School of Medical Laboratory Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
4: HIV/AIDS and TB Research Directorate, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Articles cited by this ↗

Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med (2007) 8.81

Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study. Lancet Infect Dis (2011) 7.23

Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet (2010) 7.07

Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients. Eur Respir J (2012) 2.45

Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review. BMC Infect Dis (2012) 2.42

Clinical significance of lipoarabinomannan detection in urine using a low-cost point-of-care diagnostic assay for HIV-associated tuberculosis. AIDS (2012) 2.28

Diagnostic evaluation of urinary lipoarabinomannan at an Ethiopian tuberculosis centre. Scand J Infect Dis (2001) 2.26

Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples. PLoS One (2010) 2.03

Lipoarabinomannan and related glycoconjugates: structure, biogenesis and role in Mycobacterium tuberculosis physiology and host-pathogen interaction. FEMS Microbiol Rev (2011) 1.88

Urine for the diagnosis of tuberculosis: current approaches, clinical applicability, and new developments. Curr Opin Pulm Med (2010) 1.73

Advances in the diagnosis of tuberculosis. Respirology (2010) 1.50

Diagnostic accuracy of a point-of-care urine test for tuberculosis screening among newly-diagnosed HIV-infected adults: a prospective, clinic-based study. BMC Infect Dis (2014) 1.32

A comparative study of two different methods for the detection of latent tuberculosis in HIV-positive individuals in Chile. Int J Infect Dis (2008) 1.16

Value of urine lipoarabinomannan grade and second test for optimizing clinic-based screening for HIV-associated pulmonary tuberculosis. J Acquir Immune Defic Syndr (2015) 1.10

HIV-1 Tat reduces nephrin in human podocytes: a potential mechanism for enhanced glomerular permeability in HIV-associated nephropathy. AIDS (2007) 1.00

Tuberculosis: diagnostics. Tuberculosis (Edinb) (2007) 0.88